Dori Thomas-Karyat

Geçmiş katılımlar

• 3rd ADC Payload Summit

  4–6 Nov 2026Boston, United States of America

  • KonuşmacıRedefining ADC Payload Design Through Targeted Biology to Expand the Therapeutic Window
• Oncology & Immunology Innovation Partnering & Licensing Summit

  9–10 Sept 2026Boston, United States of America

  • PanelReflecting on the First Attempts with Novel Payloads & What we are Doing Differently Nowİle: Paul Moore, Abizer Gaslightwala, Robert Lutz

Şu etkinlikteki diğer konuşmacılar: 3rd ADC Payload Summit

• Robert Lutz

  Chief Scientific Officer, Iksuda Therapeutics

• Vicky Appleman

  Director, Oncology Drug Discovery, Takeda

• Tara Arvedson

  Chief Scientific Officer, Hexagon Bio

• Prajna Behera

  Senior Principal Scientist, Oncology Innovation, GlaxoSmithKline

• Krzysztof Brzózka

  Chief Scientific Officer, Ryvu Therapeutics

• Wanping Geng

  Vice President, CanWell Pharma

Etkinlik sayfasında 16 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: Oncology & Immunology Innovation Partnering & Licensing Summit

• Carla Bauer

  Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

• Akihiro Furukawa

  Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo

• Adam Gilbert

  Science Partner, Flagship Pioneering

• Mike Jones

  Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical

• Jason Kantor

  Chief Business Officer, Nurix Therapeutics, Inc.

• Nikhil Mutyal

  Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

Etkinlik sayfasında 55 konuşmacının tümünü gör